[
1. Anon. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine: Guidance for Industry, Bioanalytical Method Validation, 2001.
]Search in Google Scholar
[
2. Anon. European Medicines Agency (EMEA): Guideline on bioanalytical method validation, 2011.
]Search in Google Scholar
[
3. Benchaoui H.A., Nowakowski M., Sherington J., Rowan T.G., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Therap 2004, 27, 203-210.10.1111/j.1365-2885.2004.00586.x15305848
]Search in Google Scholar
[
4. Bohm D.A., Stachel C.S., Gowik P.: Multi-method for the determination of antibiotics of different substance groups in milk and validation in accordance with Commission Decision 2002/657/EC. J Chromatogr A 2009, 1216, 8217-8223.10.1016/j.chroma.2009.06.05819615688
]Search in Google Scholar
[
5. Boner P.L., Gottschall D.W., Kim-Kang H.: Determination and confirmation of tulathromycin residues in bovine liver and porcine kidney via their common hydrolytic fragment using high-performance liquid chromatography/tandem mass spectrometry. J AOAC Int 2011, 94, 436-445.10.1093/jaoac/94.2.436
]Search in Google Scholar
[
6. Charles L., Segreti J.: Choosing the right macrolide antibiotic. A guide to selection. Drugs 1997, 53, 349-357.10.2165/00003495-199753030-000029074839
]Search in Google Scholar
[
7. Darrington R.T., Zhang L., Ji Q., Rafka R.J., Morton B.J.: Equilibrium, kinetics, and mechanism of acyl migration in tulathromycin, a novel triamilide antibiotic. AAPS Pharm Sci 2003, 5 , 1187-1189.
]Search in Google Scholar
[
8. Galer D., Hessong S., Beato B., Risk J., Inskeep P., Weerasinghe C., Schneider R., Langer C., LaPerle J., Renouf D., Bessire A., Español E., Rafka R., Ragan C., Boettner W., Murphy T., Keller D., Benchaoui H., Nowakowski M.: An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung. J Agric Food Chem 2004, 52, 2179-2191.10.1021/jf035162415080618
]Search in Google Scholar
[
9. Martos P.A., Lehotay S.J., Shurmer B: Ultratrace analysis of nine macrolides, including tulathromycin A (Draxxin), in edible animal tissues with minicolumn liquid chromatography tandem mass spectrometry. J Agric Food Chem 2008, 56, 8844-8850.10.1021/jf801747u18778062
]Search in Google Scholar
[
10. Nowakowski M.A., Inskeep P.B., Risk J.E., Skogerboe T.L., Benchaoui H.A., Meinert T.R., Sherington J., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic in cattle. Vet Therap 2004, 5, 60-74.
]Search in Google Scholar
[
11. Nutsch R.G., Hart F.J., Rooney K.A., Weigel D.J., Kilgore W.R., Skogerboe T.L.: Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease. Vet Therapeutics: Res Appl Vet Med 2005, 6, 214-224.
]Search in Google Scholar
[
12. Scheuch E., Spieker J., Venner M., Siegmund W.: Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry. J Chromatogr B 2007, 850, 464-470.10.1016/j.jchromb.2006.12.03417267304
]Search in Google Scholar
[
13. Wang X., Tao Y.F., Huang L.L., Chen D.M., Yin S.Z., Ihsan A., Zhou W., Su S.J., Liu Z.L., Pan Y.H., Yuan Z.H.: Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. J Vet Pharmacol Therap 2012, 35, 282-289.10.1111/j.1365-2885.2011.01322.x21749408
]Search in Google Scholar
[
14. Young G., Smith G.W., Leavens T.L., Wetzlich S.E., Baynes R.E., Mason S.E., Riviere J.E., Tell L.A.: Pharmacokinetics of tulathromycin following subcutaneous administration in meat goats. Res Vet Sci 2011, 90, 477-479.10.1016/j.rvsc.2010.06.02520638089
]Search in Google Scholar
[
15. Zhanel G.G., Dueck M., Hoban D.J., Vercaigne L.M., Embil J.M., Gin A.S., Karlowski J.A.: Review of macrolides and ketolides - focus on respiratory tract infections. Drugs 2001, 61, 443-498.10.2165/00003495-200161040-0000311324679
]Search in Google Scholar
